Regarding the PUFAs, it has been reported that combined EPA-DHA treatment negatively affects leptin and obesity-related membrane-type MT1-MMP (MMP-14) mRNA expression in rabbit subcutaneous ASCs in vitro [66]. The gene discussed is MMP14; the disease is obesity disorder.